Treatment of bronchial asthma - A simplified overview. [PDF]
Harvanová G, Duranková S.
europepmc +1 more source
Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study. [PDF]
Alcázar-Navarrete B +15 more
europepmc +1 more source
Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study. [PDF]
Rebordosa C +9 more
europepmc +1 more source
Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA adverse event reporting system database. [PDF]
Lan Y, Hu D, Huang S, Xu M, He Q.
europepmc +1 more source
Direct healthcare cost comparison of fluticasone/salmeterol and budesonide/formoterol maintenance and reliever therapy for moderate to severe asthma in the South African public sector. [PDF]
Leong TD, Besada D.
europepmc +1 more source
Corrigendum to: Sheikh S, Eisner M, Wheaton K, et al. Intermittent Asthma and Risk of Severe Exacerbation in Children. CHEST. 2026;169(1):41-51. [PDF]
europepmc +1 more source
Activation of β2-Adrenergic Receptor Alleviates Viral Myocarditis by Regulating Energy Metabolism in Monocyte-derived Macrophages via the AMPK Pathway. [PDF]
Li QL +5 more
europepmc +1 more source
Real-world evaluation of adherence to single-inhaler triple therapy in chronic obstructive pulmonary disease: the LIFE Study. [PDF]
Ogata H +6 more
europepmc +1 more source
Efficacy of Yupingfeng powder in the treatment of bronchial asthma in adults: a systematic review and meta-analysis. [PDF]
Zhang Q +5 more
europepmc +1 more source
Efficacy of single-inhaler triple therapies for chronic obstructive pulmonary disease: a systematic review and network meta-analysis. [PDF]
Zhang Y, Zhao P, Zhang Y.
europepmc +1 more source

